Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1996 May;223(5):600–609. doi: 10.1097/00000658-199605000-00016

Pyogenic hepatic abscess. Changing trends over 42 years.

C J Huang 1, H A Pitt 1, P A Lipsett 1, F A Osterman Jr 1, K D Lillemoe 1, J L Cameron 1, G D Zuidema 1
PMCID: PMC1235191  PMID: 8651751

Abstract

OBJECTIVE: The authors document changes in the etiology, diagnosis, bacteriology, treatment, and outcome of patients with pyogenic hepatic abscesses over the past 4 decades. SUMMARY BACKGROUND DATA: Pyogenic hepatic abscess is a highly lethal problem. Over the past 2 decades, new roentgenographic methods, such as ultrasound, computed tomographic scanning, direct cholangiography, guided aspiration, and percutaneous drainage, have altered both the diagnosis and treatment of these patients. A more aggressive approach to the management of hepatobiliary and pancreatic neoplasms also has resulted in an increased incidence of this problem METHODS: The records of 233 patients with pyogenic liver abscesses managed over a 42-year period were reviewed. Patients treated from 1952 to 1972 (n = 80) were compared with those seen from 1973 to 1993 (n = 153). RESULTS: From 1973 to 1993, the incidence increased from 13 to 20 per 100,000 hospital admissions (p < 0.01. Patients managed from 1973 to 1993 were more likely (p < 0.01) to have an underlying malignancy (52% vs. 28%) with most of these (81%) being a hepatobiliary or pancreatic cancer. The 1973 to 1993 patients were more likely (p < 0.05) to be infected with streptococcal (53% vs. 30%) or Pseudomonas (30% vs. 9%) species or to have mixed bacterial and fungal 26% vs. 1%) infections. The recent patients also were more likely (p < 0.05) to be managed by percutaneous abscess drainage (45% vs. 0%). Despite having more underlying problems, overall mortality decreased significantly (p < 0.01) from 65% (in 1952 to 1972 period) to 31% (in 1973 to 1993 period). The reduction was greatest for patients with multiple abscesses (88% vs. 44%; p < 0.05) with either a malignant or a benign biliary etiology (90% vs. 38%; p < 0.05). Mortality was increased (p < 0.02) in patients with mixed bacterial and fungal abscesses (50%). From 1973 to 1993, mortality was lower (p = 0.19) with open surgical as opposed to percutaneous abscess drainage (14% vs. 26%). CONCLUSIONS: Significant changes have occurred in the etiology, diagnosis, bacteriology, treatment, and outcome patients with pyogenic hepatic abscesses over the past 4 decades. However, mortality remains high, and proper management continues to be a challenge. Appropriate systemic antibiotics and fungal agents as well as adequate surgical, percutaneous, or biliary drainage are required for the best results.

Full text

PDF
600

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Branum G. D., Tyson G. S., Branum M. A., Meyers W. C. Hepatic abscess. Changes in etiology, diagnosis, and management. Ann Surg. 1990 Dec;212(6):655–662. doi: 10.1097/00000658-199012000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chou F. F., Sheen-Chen S. M., Chen Y. S., Chen M. C., Chen F. C., Tai D. I. Prognostic factors for pyogenic abscess of the liver. J Am Coll Surg. 1994 Dec;179(6):727–732. [PubMed] [Google Scholar]
  3. Donovan A. J., Yellin A. E., Ralls P. W. Hepatic abscess. World J Surg. 1991 Mar-Apr;15(2):162–169. doi: 10.1007/BF01659049. [DOI] [PubMed] [Google Scholar]
  4. Giorgio A., Tarantino L., Mariniello N., Francica G., Scala E., Amoroso P., Nuzzo A., Rizzatto G. Pyogenic liver abscesses: 13 years of experience in percutaneous needle aspiration with US guidance. Radiology. 1995 Apr;195(1):122–124. doi: 10.1148/radiology.195.1.7892451. [DOI] [PubMed] [Google Scholar]
  5. Lambiase R. E., Deyoe L., Cronan J. J., Dorfman G. S. Percutaneous drainage of 335 consecutive abscesses: results of primary drainage with 1-year follow-up. Radiology. 1992 Jul;184(1):167–179. doi: 10.1148/radiology.184.1.1376932. [DOI] [PubMed] [Google Scholar]
  6. Lamminen A. E., Anttila V. J., Bondestam S., Ruutu T., Ruutu P. J. Infectious liver foci in leukemia: comparison of short-inversion-time inversion-recovery, T1-weighted spin-echo, and dynamic gadolinium-enhanced MR imaging. Radiology. 1994 May;191(2):539–543. doi: 10.1148/radiology.191.2.8153336. [DOI] [PubMed] [Google Scholar]
  7. Lee K. T., Sheen P. C., Chen J. S., Ker C. G. Pyogenic liver abscess: multivariate analysis of risk factors. World J Surg. 1991 May-Jun;15(3):372–377. doi: 10.1007/BF01658732. [DOI] [PubMed] [Google Scholar]
  8. Marcus S. G., Walsh T. J., Pizzo P. A., Danforth D. N., Jr Hepatic abscess in cancer patients. Characterization and management. Arch Surg. 1993 Dec;128(12):1358–1364. doi: 10.1001/archsurg.1993.01420240066012. [DOI] [PubMed] [Google Scholar]
  9. Mischinger H. J., Hauser H., Rabl H., Quehenberger F., Werkgartner G., Rubin R., Deu E. Pyogenic liver abscess: studies of therapy and analysis of risk factors. World J Surg. 1994 Nov-Dec;18(6):852–858. doi: 10.1007/BF00299085. [DOI] [PubMed] [Google Scholar]
  10. Méndez R. J., Schiebler M. L., Outwater E. K., Kressel H. Y. Hepatic abscesses: MR imaging findings. Radiology. 1994 Feb;190(2):431–436. doi: 10.1148/radiology.190.2.8284394. [DOI] [PubMed] [Google Scholar]
  11. Nordback I. H., Pitt H. A., Coleman J., Venbrux A. C., Dooley W. C., Yeu N. N., Cameron J. L. Unresectable hilar cholangiocarcinoma: percutaneous versus operative palliation. Surgery. 1994 May;115(5):597–603. [PubMed] [Google Scholar]
  12. Pennington L., Kaufman S., Cameron J. L. Intrahepatic abscess as a complication of long-term percutaneous internal biliary drainage. Surgery. 1982 Jun;91(6):642–645. [PubMed] [Google Scholar]
  13. Pitt H. A., Nakeeb A., Abrams R. A., Coleman J., Piantadosi S., Yeo C. J., Lillemore K. D., Cameron J. L. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg. 1995 Jun;221(6):788–798. doi: 10.1097/00000658-199506000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pitt H. A. Surgical management of hepatic abscesses. World J Surg. 1990 Jul-Aug;14(4):498–504. doi: 10.1007/BF01658675. [DOI] [PubMed] [Google Scholar]
  15. Pitt H. A., Zuidema G. D. Factors influencing mortality in the treatment of pyogenic hepatic abscess. Surg Gynecol Obstet. 1975 Feb;140(2):228–234. [PubMed] [Google Scholar]
  16. Robert J. H., Mirescu D., Ambrosetti P., Khoury G., Greenstein A. J., Rohner A. Critical review of the treatment of pyogenic hepatic abscess. Surg Gynecol Obstet. 1992 Feb;174(2):97–102. [PubMed] [Google Scholar]
  17. Stain S. C., Yellin A. E., Donovan A. J., Brien H. W. Pyogenic liver abscess. Modern treatment. Arch Surg. 1991 Aug;126(8):991–996. doi: 10.1001/archsurg.1991.01410320077010. [DOI] [PubMed] [Google Scholar]
  18. Wong E., Khardori N., Carrasco C. H., Wallace S., Patt Y., Bodey G. P. Infectious complications of hepatic artery catheterization procedures in patients with cancer. Rev Infect Dis. 1991 Jul-Aug;13(4):583–586. doi: 10.1093/clinids/13.4.583. [DOI] [PubMed] [Google Scholar]
  19. Yinnon A. M., Hadas-Halpern I., Shapiro M., Hershko C. The changing clinical spectrum of liver abscess: the Jerusalem experience. Postgrad Med J. 1994 Jun;70(824):436–439. doi: 10.1136/pgmj.70.824.436. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES